α-Fetoprotein maybe “dead-and-buried“ as a marker of hepatocellular carcinoma in resource-rich countries, but it is still “alive-and-well“ and needed in Sub-Saharan Africa

By Kew M.  

Journal africain du cancer / African Journal of Cancer, Vol. 5, Iss. 1, 2013-02 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer in Sub-Saharan Africa: opportunities for prevention

By Brinton Louise   Figueroa Jonine   Awuah Baffour   Yarney Joel   Wiafe Seth   Wood Shannon   Ansong Daniel   Nyarko Kofi   Wiafe-Addai Beatrice   Clegg-Lamptey Joe  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 467-478

Springer Publishing Company

Access to resources Recommend Favorite

Ductal carcinoma in situ: how should we treat it?

By Bayraktar Soley   Arun Banu   Glück Stefan  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite

Inflammatory Breast Carcinoma: Pathological or Clinical Entity?

By Amparo R.S.  

Breast Cancer Research and Treatment, Vol. 64, Iss. 3, 2000-12 ,pp. : 269-273

Springer Publishing Company

Access to resources Recommend Favorite

Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma

By                

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1139-1146

Spandidos Publications

Access to resources Recommend Favorite